日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study

原发性多发性骨髓瘤与继发性多发性骨髓瘤的比较分析:一项倾向评分匹配研究

Jang, Yoon Jung; Kong, Joonseog; Kim, Heyjin; Pak, Chulkue; Na, Im Il; Lee, Hyo-Rak; Kang, Hye Jin

Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study

肉瘤患者继发性血液系统恶性肿瘤:一项单中心回顾性研究

Jang, Yoon Jung; Jeong, Hong Kyu; Kong, Chang-Bae; Song, Won Seok; Cho, Wan Hyeong; Jeon, Dae Geun; Kim, Heyjin; Yang, Sung Hyun; Na, Im Il; Lee, Hyo-Rak; Kang, Hye Jin

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors

EGFR突变与第二原发性肺癌和乳腺癌幸存者HER2表达的相关性

Jang, Yoon Jung; Kim, Seo Yun; Jung, Hong Kyu; Kim, Hye-Ryoun; Kim, Cheol Hyeon; Lee, Hyo-Rak; Kang, Hye Jin; Yang, Sung Hyun; Seol, Hyesil; Na, Im Il

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study

FOLFIRINOX 减毒方案挽救治疗吉西他滨难治性晚期胰腺癌:一项 II 期研究

Kim, Jung Hoon; Lee, Sang-Cheol; Oh, Sung Yong; Song, Seo-Young; Lee, Namsu; Nam, Eun Mi; Lee, Soonil; Hwang, In Gyu; Lee, Hyo Rak; Lee, Kyu Taek; Bae, Sang-Byung; Kim, Han Jo; Jang, Joung Soon; Lim, Do Hyoung; Lee, Hyun Woo; Kang, Seok Yun; Kang, Jung Hun

A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer

一项针对转移性或复发性胃癌患者的紫杉醇、5-氟尿嘧啶(5-FU)和顺铂的II期临床试验

Kang, Gun Hi; Kim, Gwang Sil; Lee, Hyo Rak; Yuh, Young Jin; Kim, Sung Rok

Gemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study

吉西他滨联合卡铂化疗治疗老年晚期非小细胞肺癌患者:一项可行性研究

Yuh, Young Jin; Lee, Hyo Rak; Kim, Sung Rok